Molecular targets and methods for formulation screening and preservative efficacy testing

Patent metadata

Field	Value
Publication number	US-9512474-B2
Application number	US-201214342171-A
Country	US
Kind code	B2
Filing date	Sep 28, 2012
Priority date	Sep 28, 2011
Publication date	Dec 6, 2016
Grant date	Dec 6, 2016

Abstract

Methods and kits are disclosed for distinguishing viable from nonviable microbial cells. The methods and kits are useful in the screening of cell culture formulations and the testing of preservative efficacy. The methods involve the amplification and quantitation of microbe-specific DNA from precursor rRNA or Elongation Factor 3 mRNA in treated versus nontreated test samples using the reverse transcription polymerase chain reaction.

First claim

What is claimed is:

1. A method for identifying and quantifying viable microbial cells in one or more samples containing a microorganism of interest, comprising:
(a) amplification of species-specific DNA from pre-rRNA-containing samples using a reverse transcription-polymerase chain reaction, said amplification step comprising:
using a first primer complementary to a pre-rRNA region of said microorganism of interest;
using a second primer complementary to a mature rRNA region of said microorganism of interest; and
performing multiple cycles of amplification using said first primer and said second primer to yield detectable levels of amplified species-specific DNA; and

(b) quantitation of said amplified species-specific DNA, said quantitation step comprising:
using a fluorescently labeled hybridizing probe complementary to said mature rRNA region of said microorganism of interest;
using said first primer complementary to said pre-rRNA region of said microorganism of interest;
using said second primer complementary to said mature rRNA region of said microorganism of interest; and
performing multiple cycles of amplification using said fluorescently labeled hybridizing probe and said first primer and said second primer to yield increasing levels of fluorescence signal above fluorescence background;

wherein said amplification of said species-specific DNA indicates the presence of said viable microbial cells in said one or more samples,
wherein at least one of said first primer, said second primer or said probe comprise nucleic acids complementary to the mRNA of the Elongation Factor 3 gene, and
wherein said quantitation of said amplified species-specific DNA provides a relative measurement of the amount of said viable microbial cells in said one or more samples.

2. The method of claim 1 , wherein said microorganism of interest is selected from the group consisting of Escherichia coli, Serratia marcescens , and Bacillus subtilis , and further wherein said first primer, said second primer, and said fluorescently labeled hybridizing probe are designed on the 3′-end of 16S rRNA.

3. The method of claim 1 , wherein said microorganism of interest is selected from the group consisting of Pseudomonas aeruginosa, Staphylococcus aureus , and Staphylococcus epidermidis , and further wherein said first primer, said second primer, and said fluorescently labeled hybridizing probe are designed on the 5′-end of 23S rRNA.

4. The method of claim 1 , wherein said microorganism of interest is Aspergillus brasiliensis , and further wherein said first primer, said second primer, and said fluorescently labeled hybridizing probe are designed on the 5′-end of 5.8S rRNA.

5. The method of claim 1 , further comprising:
collecting cells onto a filter membrane and
lysing said collected cells.

6. The method of claim 1 , further comprising:
applying said amplification step and said quantitation step to both a test sample and a control sample, wherein said control sample contains non-treated cells; and
comparing the relative measurement of the amount of said viable microbial cells in said control samples to the relative measurement of the amount of said viable microbial cells in said test sample.

7. The method of claim 1 , wherein said one or more samples contains one or more cell culture formulations or preservatives in need of screening or efficacy testing.

8. A method for identifying and quantifying viable microbial cells in one or more samples containing a microorganism of interest, comprising:
(a) amplification of species-specific DNA from Elongation Factor 3 (EF-3) mRNA-containing samples using a reverse transcription-polymerase chain reaction, said amplification step comprising:
using a forward primer complementary to the EF-3 pre-rRNA region of said microorganism of interest;
using a reverse primer complementary to the EF-3 mature rRNA region of said microorganism of interest; and
performing multiple cycles of amplification using said forward primer and said reverse primer to yield detectable levels of amplified species-specific DNA; and

(b) quantitation of said amplified species-specific DNA, said quantitation step comprising:
using a fluorescently labeled forward hybridizing probe complementary to said EF-3 mature rRNA region of said microorganism of interest;
using said forward primer complementary to said EF-3 pre-rRNA region of said microorganism of interest;
using said reverse primer complementary to said EF-3 mature rRNA region of said microorganism of interest; and
performing multiple cycles of amplification using said fluorescently labeled forward hybridizing probe and said forward primer and said reverse primer to yield increasing levels of fluorescence signal above fluorescence background;

wherein said amplification of said species-specific DNA indicates the presence of said viable microbial cells in said one or more samples, and
wherein said quantitation of said amplified species-specific DNA provides a relative measurement of the amount of said viable microbial cells in said one or more samples.

9. The method of claim 8 , wherein said microorganism of interest is Candida albicans.

10. The method of claim 8 , further comprising:
collecting cells onto a filter membrane and
lysing said collected cells.

11. The method of claim 8 , further comprising:
applying said amplification step and said quantitation step to both a test sample and a control sample, wherein said control sample contains non-treated cells; and
comparing the relative measurement of the amount of said viable microbial cells in said control samples to the relative measurement of the amount of said viable microbial cells in said test sample.

12. The method of claim 8 , wherein said one or more samples contains one or more cell culture formulations or preservatives in need of screening or efficacy testing.

13. A method of cell culture formulation screening or cell culture preservative efficacy testing, comprising:
calibrating cells to a desired density;
collecting cells on a filter membrane;
applying nutrients to said membrane to yield enriched cells;
incubating said enriched cells;
removing nutrients;
adding lysis buffer to membrane;
recovering cell lysates;
transferring lysate;
extracting and purifying RNA; and
amplifying and quantitating species-specific DNA by the reverse transcription-polymerase chain reaction according to the method of claim 1 .

14. A kit, comprising:
at least one primer pair (“primers”), said primers comprising a first primer that hybridizes to a bacteria pre-rRNA region and a second primer that hybridizes to a bacteria mature rRNA region;
said primers combined with at least one probe, wherein said probe hybridizes to said bacteria mature rRNA region between said first primer and said second primer;
wherein at least one of said primers or said at least one probe comprise nucleic acids complementary to the 3′-end of 16S rRNA, nucleic acids complementary to the 5′-end of 23S rRNA, or nucleic acids complementary to the 5′-end of 5.8S rRNA; wherein at least one of said primers or said at least one probes comprise nucleic acids complementary to the mRNA of the Elongation Factor 3 gene; and
wherein at least one of said primers or said at least one probe further comprise at least one non-natural label.

15. A kit for identifying and quantifying viable microbial cells in one or more samples containing a microorganism of interest, comprising:
at least one primer pair (“primers”), said primers comprising a first primer that hybridizes to a pre-rRNA region and a second primer that hybri

Assignees

• Lonza Walkersville Inc
• Lonza Walkersville Inc

Inventors

• Seone Sophie
• Gontard Stephanie
• Coleman Timothy

Classifications

• C12Q1/6895

  for plants, fungi or algae · CPC title

• C12Q1/689 Primary

  for bacteria · CPC title

• C12Q1/686 Primary

  Polymerase chain reaction [PCR] · CPC title